These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 15212767

  • 1. Lack of cytotoxic property in a variant of Epstein-Barr virus latent membrane protein-1 isolated from nasopharyngeal carcinoma.
    Nitta T, Chiba A, Yamamoto N, Yamaoka S.
    Cell Signal; 2004 Sep; 16(9):1071-81. PubMed ID: 15212767
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Identification of functional differences between prototype Epstein-Barr virus-encoded LMP1 and a nasopharyngeal carcinoma-derived LMP1 in human epithelial cells.
    Dawson CW, Eliopoulos AG, Blake SM, Barker R, Young LS.
    Virology; 2000 Jun 20; 272(1):204-17. PubMed ID: 10873763
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1).
    Eliopoulos AG, Young LS.
    Oncogene; 1998 Apr 02; 16(13):1731-42. PubMed ID: 9582021
    [Abstract] [Full Text] [Related]

  • 7. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q, Sato H, Murono S, Furukawa M, Yoshizaki T.
    Laryngoscope; 2004 May 02; 114(5):855-9. PubMed ID: 15126743
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Differences in the immunogenicity of latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus genomes derived from LMP1-positive and -negative nasopharyngeal carcinoma.
    Hu L, Troyanovsky B, Zhang X, Trivedi P, Ernberg I, Klein G.
    Cancer Res; 2000 Oct 01; 60(19):5589-93. PubMed ID: 11034108
    [Abstract] [Full Text] [Related]

  • 10. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain.
    Huen DS, Henderson SA, Croom-Carter D, Rowe M.
    Oncogene; 1995 Feb 02; 10(3):549-60. PubMed ID: 7845680
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr virus latent membrane protein 1 modulates epidermal growth factor receptor promoter activity in a nuclear factor kappa B-dependent manner.
    Tao YG, Tan YN, Liu YP, Song X, Zeng L, Gu HH, Tang M, Li W, Yi W, Cao Y.
    Cell Signal; 2004 Jul 02; 16(7):781-90. PubMed ID: 15115657
    [Abstract] [Full Text] [Related]

  • 12. [Effects of two LMP1 variants on resistance of CNE1 cell strain to TGF-beta1].
    Huang H, Huang PC.
    Ai Zheng; 2003 Dec 02; 22(12):1254-9. PubMed ID: 14693046
    [Abstract] [Full Text] [Related]

  • 13. The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB.
    Nakamura H, Ishii C, Suehiro M, Iguchi A, Kuroda K, Shimizu K, Shimizu N, Imadome K, Yajima M, Fujiwara S.
    Virus Res; 2008 Feb 02; 131(2):170-9. PubMed ID: 17963943
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Endogenous latent membrane protein 1 in Epstein-Barr virus-infected nasopharyngeal carcinoma cells attracts T lymphocytes through upregulation of multiple chemokines.
    Lai HC, Hsiao JR, Chen CW, Wu SY, Lee CH, Su IJ, Takada K, Chang Y.
    Virology; 2010 Sep 30; 405(2):464-73. PubMed ID: 20637487
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma.
    Zheng H, Li LL, Hu DS, Deng XY, Cao Y.
    Cell Mol Immunol; 2007 Jun 30; 4(3):185-96. PubMed ID: 17601372
    [Abstract] [Full Text] [Related]

  • 20. Transcriptional activation of NF-kappa B activity by Epstein-Barr virus (EBV) LMP1 as a selective therapeutic strategy for EBV-associated diseases.
    Wu CJ, Leu CY, Liu ST, Chow KP, Meng CL, Chang YS.
    Gene Ther; 1998 Jul 30; 5(7):905-12. PubMed ID: 9813661
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.